EUVIMEDEUVIMED entdecken
Crossref

A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes

Yuedan Chen, Qu Cui, Jun Qian, Xueyan Bai, Ruixian Xing, Jing Liu, Qing Liu, Yuchen Wu, Wenyuan Lai, Huixiu Han, Yuanbo Liu, Xuefei Sun und 1 weitere

Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · 760-767.e1

DOI: 10.1016/j.clml.2026.08.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von Yuedan Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China. Hauptthemen laut MEDLINE: Central Nervous System Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Lymphoma. Die Arbeit nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Central Nervous System NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsLymphomaHumansFemaleRetrospective StudiesMaleMiddle AgedAdultAgedTreatment OutcomeDexamethasoneIfosfamideRituximabYoung Adult

Stichwörter der Autor:innen

HD-MTXImmunochemtherapyInduction treatmentPrognosisTreatment Outcome

Substanzen

DexamethasoneIfosfamideRituximab

Autor:innen und Institutionen

  • Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China.
  • Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China. Electronic address: sunxuefei@bjtth.org.
  • Department of Hematology, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China. Electronic address: fulin022@126.com.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, Y., Cui, Q., Qian, J., Bai, X., Xing, R., Liu, J., Liu, Q., Wu, Y., Lai, W., Han, H., Liu, Y., Sun, X., & Fu, L. (2026). A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes. Clinical Lymphoma Myeloma and Leukemia, 26(11), 760-767.e1. https://doi.org/10.1016/j.clml.2026.08.017

Vancouver

Chen Y, Cui Q, Qian J, Bai X, Xing R, Liu J, et al. A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes. Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):760-767.e1. doi:10.1016/j.clml.2026.08.017

BibTeX
@article{Chen2026,
  author = {Chen, Yuedan and Cui, Qu and Qian, Jun and Bai, Xueyan and Xing, Ruixian and Liu, Jing and Liu, Qing and Wu, Yuchen and Lai, Wenyuan and Han, Huixiu and Liu, Yuanbo and Sun, Xuefei and Fu, Lin},
  title = {A Single-center Retrospective Study of MIAD ± R Chemotherapy in Newly Diagnosed Primary Central Nervous System Lymphoma: Safety Profiles and Clinical Outcomes},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {11},
  pages = {760--767.e1},
  doi = {10.1016/j.clml.2026.08.017}
}
Kostenlos starten →